Latest Breaking News On - Annual psychedelics conference - Page 2 : comparemela.com

NeonMind Biosciences Inc : NeonMind to Present at H C Wainwright 2nd Annual Psychedelics Virtual Conference

VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind' or the "Company"), an integrated drug development and wellness company focused on

British columbiaRob tessaroloScott eckstein tim reganRobert tessaroloStrategic communicationsNeonmind biosciences incCanadian securities exchangeSrx health solutionsNeonmind biosciencesChief executive officerAnnual psychedelics conferenceAnnual psychedelics virtual conference detailsHealth solutions

NeonMind to Present at H C Wainwright 2nd Annual Psychedelics Virtual Conference

NeonMind to Present at H C Wainwright 2nd Annual Psychedelics Virtual Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaRob tessaroloScott eckstein tim reganRobert tessaroloStrategic communicationsNeonmind biosciences incCanadian securities exchangeSrx health solutionsWall streetNeonmind biosciencesChief executive officerAnnual psychedelics conferenceAnnual psychedelics virtual conference detailsHealth solutions

MindMed to Present at H C Wainwright 2nd Annual Psychedelics Conference

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

Robert barrowPrnewswire mind medicine mindmed incMedicine mindmed incChief executive officerAnnual psychedelics conferenceMind medicine mindmed inc

Investegate |HMNC Holding GmbH Announcements | HMNC Holding GmbH: HMNC Brain Health to Participate in the H C Wainwright 2nd Annual Psychedelics Conference

Investegate announcements from HMNC Holding GmbH, HMNC Brain Health to Participate in the H.C. Wainwright 2nd Annual Psychedelics Conference

Anne donohoeTim reganAlexander schmidt europeHans erikssonBrain health websiteStrategic communicationsHmnc brain health toHolding gmbBrain healthClinical developmentAnnual psychedelicsChief executive officerChief clinical development officerAnnual psychedelics conferenceMental healthcareHealth website

HMNC Brain Health to Participate in the H C Wainwright 2nd

MUNICH, Germany, Dec. 01, 2021 (GLOBE NEWSWIRE) HMNC Brain Health (“HMNC” or the “company”), a clinical stage biopharma company pioneering the.

Hans erikssonBrain health websiteStrategic communicationsBrain healthClinical developmentChief executive officerChief clinical development officerAnnual psychedelics conferenceMental healthcareHealth websiteHmnc holding gmbh